triumph trial retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 TRIUMPH-1 trial results: Retatrutide, the

If you have TRICARE For Life, weight loss drug coverage ended August 31, 2025

Conditions Addressed with BPC-157 Peptide Therapy Anita Petruzzelli, M.D.s goal is to provide Glastonbury patients with the most effective integrative treatments for optimal wellness

John: Get the latest Impact Podcast right into your inbox each week

Myth 3: The "Big Greasy Breakfast" Cure The Myth: Eating a heavy, greasy bacon and egg roll the morning after will "absorb" the remaining alcohol in your stomach

Among the 56 patients with complete follow-up data at 1 year, there was a significant improvement in weight-related comorbidities, including a reduction in obstructive sleep apnea syndrome ( 30%), hypertension ( 40%), arthralgia ( 56.5%), and fatty liver disease ( 36.4%)

By combining lifestyle changes with medication, we address holistic health needs and help ensure long-term results